health · education · HHS-NIH11
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
National Institutes of Health · PAR-25-321
Deadline
January 7, 2028
GRANTQUICK SUMMARYPlain-English Overview
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional). National Institutes of Health. Through this engineering-oriented Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or... Funding amounts not specified.
Who Should Apply
County governments, Nonprofits (501c3), State governments, Small businesses, Public And Indian Housing Authorities (+10 more)
Who Should NOT Apply
Organizations not matching the eligible applicant types listed above
Key Requirements (Plain English)
- •Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Is...
- •Deadline: 2028-01-07
💡 GrantQuick Tip
Focus your proposal on clear outcomes, alignment with agency priorities, and demonstrate organizational capacity.
Competitiveness: Moderate to high — federal grants are always competitive
What This Grant Funds
Attachments
Who Can Apply
Eligible Applicant Types
Funding Details
- Cost Sharing Required?
- No
- Funding Instrument
- grant
Key Dates
Agency Contact
NIH Grants Information grantsinfo@nih.gov
grantsinfo@nih.govReady to apply?
View the full NOFO and submit your application on Grants.gov